Suppr超能文献

移植时机对肾移植受者术后生存结局和围手术期并发症的影响。

Impact of Transplantation Timing on Renal Graft Survival Outcomes and Perioperative Complications.

机构信息

Urology, Centre Hospitalo-Universitaire Amiens Picardie, Amiens, France.

Urology, Centre Hospitalo-Universitaire Caen, Caen, France.

出版信息

Transpl Int. 2024 Feb 14;37:12202. doi: 10.3389/ti.2024.12202. eCollection 2024.

Abstract

Nighttime organ transplantation aims to decrease cold ischemia duration, yet conflicting data exists on its impact on graft function and perioperative complications. This multicenter TRANSPLANT'AFUF study including 2,854 patients, transplanted between 1 January 2011, and 31 December 2022, investigated nighttime kidney transplantation's impact (8:00 p.m.-8:00 a.m.) versus daytime (8:00 a.m.-8:00 p.m.) on surgical complications and graft survival. Overall, 2043 patients (71.6%) underwent daytime graft, while 811 (28.4%) underwent nighttime graft. No impact was observed of timing of graft surgery on graft survival with a median survival of 98 months and 132 months for daytime and nightime grafting, respectively ( = 0.1749). Moreover, no impact was observed on early surgical complications (Clavien I-II = 20.95% for DG and 20.10% for NG; Clavien III-IV-V = 15.42% for DG and 12.94% for NG; = 0.0889) and late complications (>30 days) (Clavien I-II = 6.80% for DG and 5.67% for NG; Clavien III-IV-V = 12.78% for DG and 12.82% for NG; = 0.2444). Noteworthy, we found a significant increase in Maastricht 3 donors' rates in nighttime transplantation (5.53% DG vs. 21.45% NG; < 0.0001). In conclusion, nighttime kidney transplantation did not impact early/late surgical complications nor graft survival.

摘要

夜间器官移植旨在减少冷缺血时间,但关于其对移植物功能和围手术期并发症的影响存在相互矛盾的数据。这项包括 2854 例患者的多中心 TRANSPLANT'AFUF 研究,于 2011 年 1 月 1 日至 2022 年 12 月 31 日期间进行,研究了夜间(晚上 8 点至早上 8 点)和日间(早上 8 点至晚上 8 点)进行肾脏移植对手术并发症和移植物存活率的影响。总体而言,2043 例患者(71.6%)接受了日间移植,811 例患者(28.4%)接受了夜间移植。研究结果显示,手术时间对移植物存活率没有影响,日间和夜间移植的中位存活时间分别为 98 个月和 132 个月(=0.1749)。此外,早期手术并发症(Clavien I-II 级:DG 为 20.95%,NG 为 20.10%;Clavien III-IV-V 级:DG 为 15.42%,NG 为 12.94%;=0.0889)和晚期并发症(>30 天)(Clavien I-II 级:DG 为 6.80%,NG 为 5.67%;Clavien III-IV-V 级:DG 为 12.78%,NG 为 12.82%;=0.2444)也没有影响。值得注意的是,我们发现夜间移植中 Maastricht 3 供体的比例显著增加(DG 为 5.53%,NG 为 21.45%;<0.0001)。总之,夜间肾脏移植不会影响早期/晚期手术并发症或移植物存活率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cd8/10899379/4afdd9b80642/ti-37-12202-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验